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Abstract
Background: Human insulin-like growth factor-I (hIGF-I) is a growth factor which is highly resemble to insulin. It is
essential for cell proliferation and has been proposed for treatment of various endocrine-associated diseases
including growth hormone insensitivity syndrome and diabetes mellitus. In the present study, an efficient plant
expression system was developed to produce biologically active recombinant hIGF-I (rhIGF-I) in transgenic rice
grains.
Results: The plant-codon-optimized hIGF-I was introduced into rice via Agrobacterium-mediated transformation. To
enhance the stability and yield of rhIGF-I, the endoplasmic reticulum-retention signal and glutelin signal peptide
were used to deliver rhIGF-I to endoplasmic reticulum for stable accumulation. We found that only glutelin signal
peptide could lead to successful expression of hIGF-I and one gram of hIGF-I rice grain possessed the maximum
activity level equivalent to 3.2 micro molar of commercial rhIGF-I. In vitro functional analysis showed that the rice-
derived rhIGF-I was effective in inducing membrane ruffling and glucose uptake on rat skeletal muscle cells. Oral
meal test with rice-containing rhIGF-I acutely reduced blood glucose levels in streptozotocin-induced and Zucker
diabetic rats, whereas it had no effect in normal rats.
Conclusion: Our findings provided an alternative expression system to produce large quantities of biologically
active rhIGF-I. The provision of large quantity of recombinant proteins will promote further research on the
therapeutic potential of rhIGF-I.
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Background
Human insulin-like growth factor-I (hIGF-I) plays a cri-
tical role in cellular differentiation, proliferation, growth
and apoptosis [1]. It is a single polypeptide chain of 70
amino acid residues and is encoded by a single gene on
chromosome 12, with a molecular weight of 7646 Da
[2,3]. It has 50% amino acid sequence homology with
insulin. Hence, hIGF-I has been proposed as an alterna-
tive therapeutic agent to treat diabetic mellitus, espe-
cially for those patients with defects in insulin receptors.
Apart from diabetes mellitus, the efficacy of hIGF-I in
the treatment of growth disorders as well as insulin
resistance has been studied [4]. In late 2005, recombi-
nant hIGF-I (rhIGF-I) was approved by the United
States Food and Drug Administration (USFDA) as a
therapeutic agent for the growth hormone insensitivity
syndrome (GHIS) [5].
Recombinant hIGF-I was first synthesized by recombi-
nant DNA techniques in 1986. To date, commercial
rhIGF-I is mainly produced in different organisms [6-8].
Problems of these processes include low expression
levels, high equipment and production costs, incorrect
post-translational modifications as well as potential con-
tamination with human pathogens. With the advance in
genetic engineering, rice is recently recognized as a pro-
mising alternative for the production of safe and
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Rice offers the advantage of producing large quantity of
proteins in terms of cost, product safety, scalability and
authenticity [9]. Rice is known to exclude any noxious
chemicals such as nicotine and toxic alkaloids in tobacco
as well as having low allergenicity. Large amount of
recombinant proteins can be synthesized at one time as a
single rice plant can produce over 1,000 grains. Besides,
as rice is self-pollinated, simple regulatory rules like isola-
tion distances can be set up to prevent cross-pollinating
and out crossing of the transgenic trait.
In an attempt to achieve high-yield expression of for-
eign genes in plants, the coding sequence of heterolo-
gous gene has to be modified to plant-preferred codons.
Previous studies have showed that codon usage biases
are strongly correlated with gene expression levels [10].
Highly expressed genes preferentially use a subset of
“optimal” codons which correspond to the most abun-
dant tRNAs, leading to enhanced translation accuracy
and efficiency [11,12]. Moreover, proteins yields can be
increased if the protein is directed to specific compart-
ments in order to prevent degradation by the proteolytic
system of the cells. In a plant cell (as in all eukaryotic
cells), an amino-terminal signal peptide can direct pro-
teins to the secretory pathway, including the endoplas-
mic reticulum (ER), the Golgi complex and hydrolytic
compartments (vacuoles in plants), or to secretion from
the cell. It has been found that secretory proteins could
be accumulated to high level than those expressed in
cytosol [13]. Some studies found that proteins yields can
be further enhanced if the protein is retained in the ER
lumen using the Lys-Asp-Glu-Leu (KDEL) C-terminal
tetrapeptide [14]. Protein levels were 6-14 times higher
in cells transformed with the construct containing
KDEL than that without KDEL [15].
In the present study, we hypothesized that functional
rhIGF-I could be produced in transgenic rice grains.
Codons of cDNA of hIGF-I was modified to plant-pre-
ferred sequences [16] and introduced into rice by Agrobac-
terium-mediated transformation. Glutelin signal peptide
and KDEL tetrapeptide were included for expression
enhancement of recombinant proteins. Biological activity
of rhIGF-I was confirmed by the induction of membrane
ruffles and the increase in glucose transport in rat skeletal
muscle cells (L6myc). In vivo study demonstrated that
transgenic rhIGF-I from rice reduced blood glucose level
in streptozotocin induced diabetic and Zucker fatty rats.
These findings confirmed that biologically active rhIGF-I
could be produced in the rice-based system.
Results
Expression of rhIGF-I in transgenic rice seeds
To increase the expression level of hIGF-I, glutelin sig-
nal peptide (SP) and ER-retention signal KDEL were
added to the chimeric constructs. Three chimeric gene
constructs (I, SI and SIK) were designed and trans-
ferred into rice by Agrobacterium-mediated transfor-
mation (Figure 1). Southern blot analysis confirmed
the integration of constructs (I, SI and SIK) into the
rice genome (Additional file 1 Figure S1). As the
restriction enzyme BamHI cuts only once in all expres-
sion constructs, the number of bands represented the
number of copies of the transgenes introduced into
rice. Most of the transformants contained 1 to 2 copies
of the transgenes, while no signal was detected in wild
type plant. Total seed protein extracts from different
transformants were examined by Tricine SDS-PAGE
and Western blot. A distinct band of about 7.6 kDa
was observed in transformants SI and SIK (Figure 2B
and 2C), whereas no signals were detected in transfor-
mant I and wild type rice plant (Figure 2A). These
results suggested that glutelin SP was essential for the
expression of the transgenes.
Ruffling effect of commercial and rice-produced rhIGF-I
Growth factors such as IGF-I and insulin are known to
cause reorganization of actin filament leading to mem-
brane ruffles [17]. Using the rat skeletal muscle cells
(L6myc), we compared the effect on actin remodeling of
rhIGF-I from commercial source and transgenic rice.
We found that the morphological change induced by
16 nM of commercial rhIGF-I was equivalent to that of
Figure 1 Expression of hIGF-I in transgenic rice.( A )N u c l e o t i d e
sequence of the modified hIGF-I cDNA. The modified nucleotide is
underlined and the change of codon was 28.6%. (B) The hIGF-I
protein is predicted to contain 70 amino acids. (C - E) The
recombinant hIGF-I expression constructs, driven by glutelin
promoter, used for rice transformation. (C) The construct, pSB130/
Gt1/hIGF-I (I) contained the modified hIGF-I alone. (D) The construct,
pSB130/Gt1/SP/hIGF-I (SI) contained glutelin signal peptide only (E)
whereas the pSB130/Gt1/SP/hIGF-I/KEDL (SIK) construct carried both
the glutelin signal peptide and KDEL. (F) All the chimeric genes
were ligated into the twin T-DNA binary vector, pSB130, for
Agrobacterium transformation. The pSB130 vector, contains two T-
DNAs, one flanking the gene of interest driven by Gt1 promoter
while the other flanking the selectable marker, hygromycin
phosphotransferase (HYG). (Abbreviations: RB - right border; LB - left
border.)
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function of rice-produced rhIGF-I, seed crude protein
extracts of various amount from different transformants
(0, 0.625, 1.25, 2.5, 5 and 10 mg) and commercial
rhIGF-I (4, 8 and 16 nM) were added to L6myc cells.
Membrane ruffles were found only when SI protein was
added (Figure 3B), while no morphological changes
were observed when L6myc cells were treated with I,
SIK (data not shown) or wild type rice (Figure 3B d). As
depicted in Figure 3C, the ruffling effect induced by SI
protein was directly proportional to the amount of the
protein added. Extract containing 5 mg of SI protein
caused membrane ruffling similar to that of 16 nM of
commercial rhIGF-I (area of ruffles: 27.00 ± 1.73% vs.
27.60 ± 1.92%).
Glucose uptake assay
The metabolic effect of rhIGF-I was studied by measur-
ing the glucose uptake in L6myc cells. Only SI protein
w a st e s t e da si tp o s s e s s e db i o l o g i c a la c t i v i t ya sd e m o n -
strated by membrane ruffle experiments. Different con-
centrations of commercial rhIGF-I (1, 4, 8 and 16 nM)
and SI protein (1.25, 2.5 and 5 mg) were added to
L6myc cells. Insulin (100 nM) was used as positive con-
trol. As depicted in Figure 4, both commercial rhIGF-I
and SI proteins stimulated glucose uptake in a dose-
dependent manner. Five mg of SI protein was found to
cause comparable glucose uptake as 8 nM of commer-
cial rhIGF-I (7.40 ± 0.79 cpm/protein vs. 7.80 ± 1.03
cpm/protein). No significant difference in glucose
uptake was observed when basal or wild type rice seed
proteins were added.
In vivo feeding test
To determine in vivo glucose lowering effect, different
animal models of diabetes, namely streptozotocin-
induced diabetic rats (STZ, a model of type 1 diabetes,
n = 8) and Zucker diabetic fatty rats (ZDF, a model of
type 2 diabetes, n = 8) were fed with transgenic rhIGF-I
rice (SI). Sprague-Dawley (SD) rats were used as control
(n = 5). Plasma glucose levels of SD rats fed with SI rice
were similar to those fed with wild type rice (Figure
5A). In Zucker fatty rats (Figure 5B) and STZ-induced
diabetic rats (Figure 5C), ingestion of SI rice was asso-
ciated with lower plasma glucose levels when compared
with those fed with wild type rice. Significant differences
were observed at 2 hours (1.41 ± 0.20 fold vs. 1.82 ±
0.19 fold, p = 0.001) and 2.5 hours (1.25 ± 0.18 fold vs.
1.51 ± 0.17 fold, p = 0.009) for Zucker fatty rats, while
for STZ-induced diabetic rats, significant differences
occurred at 2.5 hours (1.12 ± 0.07 fold vs. 1.28 ± 0.14
fold, p = 0.01) and 3 hours (1.06 ± 0.06 fold vs. 1.19 ±
0.07 fold, p = 0.001). The results indicated that SI rice
reduced blood glucose in Zucker fatty and STZ-induced
diabetic rats, though it had no effect on blood glucose
level in normal SD rats.
Starch contents of rice grains
Total starch analysis was performed to confirm the
endogenous starch contents of SI transgenic rice and
wild type rice. The OD reading of SI and wild type rice
were 0.574 ± 0.019 vs. 0.590 ± 0.023, p = 0.119) respec-
tively (Additional file 2 Figure S2). The result suggested
that both transgenic and wild type rice grains had simi-
lar starch content.
Discussion
This is the first report to demonstrate the expression of
native rhIGF-I in transgenic rice grains. Various strate-
gies were employed in the design of the chimeric con-
structs to enhance the stable expression of the human
recombinant proteins in plant. Firstly, the codons of
human IGF-I gene were modified to plant-preferred
sequence. Secondly, sequences of two plant seed storage
proteins, lysine-rich protein (LRP) from winged bean
and methionine-rich 2S albumin from Paradise nut [16]
were included in constructs for high protein expression
and stable accumulation [18,19]. Thirdly, as subcellular
targeting is another crucial factor in determining the
expression of foreign proteins, rice glutelin signal pep-
tide (SP) and ER-retention sequence KDEL were
employed for stable accumulation of rhIGF-I in trans-
genic rice grains. Western blot analysis showed that
only constructs containing SP and KDEL (SI and SIK)
were expressed in transgenic rice grains (Figure 2). We
postulated that the addition of SP promotes the inclu-
sion of candidate proteins SI and SIK into the secretory
Figure 2 Western blot analysis of different transgenic rice
seeds. Total protein (150 ug) was extracted from mature rice seeds
of different transformants, blotted onto PVDF membrane.
Recombinant rhIGF-I protein was used as positive controls. (A) Lane
1: wild type rice plant (wt); lanes 2-5: pSB/Gt1/hIGF-I transformants
I1 to I4; lane 6: positive control (+ve) - commercial rhIGF-I protein.
(B) Lane 1: wild type rice plant (wt); lane 2: positive control (+ve) -
commercial rhIGF-I protein; lanes 3-6: pSB/Gt1/SP/hIGF-I
transformants SI1 to SI4. (C) Lane 1: wild type rice plant (wt); lane 2:
positive control (+ve) - commercial rhIGF-I protein; lanes 3-6: pSB/
Gt1/SP/hIGF-I::KDEL transformants SIK1 to SIK4.
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the cleavage of SP in the ER, the SI protein, in the
absence of further protein sorting sequences, went
through the Golgi apparatus and was finally secreted
out of the cell in the intercellular space for storage. In
contrast, the SIK protein was re-directed and retained in
the ER by the presence of KDEL sequence. The KDEL
tetrapeptide contributes to protein localization by inter-
acting with a receptor that recycles between the Golgi
apparatus and the ER [14]. The oxidizing environment
and the presence of molecular chaperones in ER pro-
mote protein assembly and folding. Furthermore, few
Figure 3 Membrane ruffling effects induced by insulin, commercial and rice-produced rhIGF-I proteins on L6 myotubes.( A )
Morphology of membrane ruffling effects induced by insulin and commercial rhIGF-I (200×). a) Normal L6 muscle cells. After adding b) 100 nM
of insulin and c) 16 nM of commercial rhIGF-I, the actin filaments of L6 cells were reorganized and looked like human winkle. (B) Morphology of
membrane ruffling effects induced by commercial and rice-produced rhIGF-I (SI) (200×). The ruffling effect was estimated by dividing each
results photo into nine hundreds equal squares. Commercial rhIGF-I (4, 8 and 16 nM), SI seed crude protein extract (0.625 - 10 mg) were used to
treat L6 cells. Wild type rice (12 mg) seed crude protein and protein extraction buffer (basal) were the negative controls. The average number of
squares showing ruffling in any three photos was counted and the percentage of ruffling was calculated. The squares showing ruffling were
marked in blue. a) Commercial rhIGF-I 4 nM; b) Commercial rhIGF-I 8 nM; c) Commercial rhIGF-I 16 nM; d) Wild type rice 12 mg; e) Protein
extraction buffer, basal; f) SI 0.625 mg; g) SI 1.25 mg; h) SI 2.5 mg; i) SI 5 mg; J) SI 10 mg. (C) A graph showing membrane ruffling effects
induced by commercial and rice-produced rhIGF-I (SI). The three columns on the left hand side represented the ruffling effect induced by 4, 8
and 16 nM of commercial rhIGF-I while the remaining indicated membrane ruffling caused by 0 - 10 mg of SI seed crude protein. Data are
shown as means ± SD.
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Hence, both SI and SIK proteins were not degraded by
protease and could be stably accumulated. Our results
were consistent with the increased accumulation of vici-
lin, a pea vacuole storage protein in transgenic alfalfa
leaves when the KDEL signal was included in C-termi-
nus [21].
Despite being expressed in the transgenic rice grain,
SIK protein failed to induce membrane ruffling in
L6myc cells. This results suggested that SIK protein was
devoid of biological activity of IGF-I. In native human
IGF-I protein, there are no glycosylation site. A possible
explanation of the difference in biological activity
between SI and SIK proteins could be related to the gly-
cosylation of candidate protein. The presence of the
KDEL sequence has been shown to affect the extent of
glycosylation in the ER and Golgi apparatus [22]. It is
feasible that the presence of the KDEL sequence in SIK
proteins might enhance the glycosylation of candidate
proteins. Further study on the presence of glycosylation
in SIK will be required to confirm the hypothesis. Other
possible explanation includes the misfolding of candi-
date protein while in the ER. The increase in SIK pro-
tein in the ER may lead to ER stress, resulting in over-
expression of ER chaperones, luminal binding protein
(BiP) and the protein folding catalyst, protein disul-
phide-isomerase [23]. Previous studies had reported that
over-expression of BiP had inhibitory effect on protein
translation, folding and deposition of storage proteins
into rice endosperm [23,24]. Our results were consistent
with previous study in which the fluorescence intensity
of green fluorescent protein with KDEL was reduced as
a result of protein misfolding [25].
The membrane ruffling and glucose uptake in rat skele-
tal muscle cells (L6myc) were used to evaluate the biolo-
gical activity of transgenic rhIGF-I. Growth factors
including IGF-I are known to cause rapid actin remodel-
ing leading to membrane ruffles [17]. The IGF-I has been
shown to be about 10 - 100 times more potent than insu-
lin in causing membrane ruffles [26]. In the present
study, 16 nM of commercial rhIGF-I was found to have
similar effect in membrane ruffles as compared to 100
nM of insulin in L6myc. Importantly, rice-produced
rhIGF-I (SI) was found to induce similar membrane ruf-
fling as commercial rhIGF-I and the effect was dose-
dependent (Figures 3B and 3C). In term of membrane
ruffles, one gram of SI rice grain possessed equivalent
activity to 3.2 μM of commercial rhIGF-I. For glucose
uptake study, 5 mg of SI protein was found to be equiva-
lent to 8 nM of commercial rhIGF-I (Figure 4). Hence, it
was estimated that one gram of SI rice grain contained
1.6 μM of functional rhIGF-I. Taken together, these
results indicated that the properties of rice-produced
r h I G F - Iw e r eq u i t es i m i l a rt ot h o s eo ft h en a t i v eI G F - I
and insulin on membrane ruffles and glucose uptake.
Schoenle et al. previously showed that treatment with
IGF-I reduced both insulin and blood glucose levels in
patients with severe insulin resistance [27]. It has been
postulated that IGF-I might enhance insulin secretion
Figure 5 Comparisons of oral rice tolerance test (ORTT)
between rice seed extracts of wild type rice (WT) and
transgenic IGF-I rice (SI) on different type of rats. (A) Normal SD
rats (n = 5), (B) Zucker fatty rats (n = 8) and (C) STZ rats (n = 8).
Blood glucose levels at different time points were measured by
multiple of increase after feeding with rice extract. Data are shown
as means ± SD. *p < 0.05, **p < 0.01.
Figure 4 Comparison of glucose uptake effects between
commercial rhIGF-I and transgenic rice seed extracts (SI) on L6
cells. Different concentrations of commercial rhIGF-I (1 nM to 16 nM)
and SI seed crude proteins (1.25 mg to 5 mg) were added to the L6
cells and the effects on glucose uptake were measured. Insulin (100
nM) was the positive control while basal was the negative control.
Data are shown as means ± SD. *p < 0.05, **p < 0.01.
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as well as prevent b cell from apoptosis [31,32] in
patients with diabetes. To evaluate whether the rice-
derived rhIGF-I could also lower blood glucose level, an
oral rice tolerance test (ORTT) was developed based
upon the methodology of oral glucose tolerance test. As
starch contributes 80% of rice grain, glucose released
after digestion will lead to higher blood glucose level,
which is similar to the effect of glucose intake. We
found that SI could efficiently lower blood glucose levels
in Zucker and STZ-induced rats (Figures 5B and 5C),
whereas it did not have significant effect in normal SD
rats (Figure 5A) when compared with wild type rice.
Blood glucose levels only showed significant differences
after 2 hours in Zucker fatty rats and 2.5 hours in STZ
rats. This time delay may be due to the release of rice-
derived rhIGF-I after digestion of SI rice grain powder.
When feeding the three types of rats with equal amount
of commercial rhIGF-I, no significant differences were
found in blood glucose levels (data not shown), suggest-
ing that commercial rhIGF-I might be totally degraded
as it went through the gastrointestinal tract in rats. On
the other hand, rice grain might help protect the rice-
derived rhIGF-I from the digestive system in rats. This
effect might be attributed to the location of rhIGF-I
accumulated in rice grain. Seed protein is normally
deposited in storage organelles known as protein bodies
[33]. Studies found that protein bodies can withstand
the harsh acidic environment of the digestive tract in
rats, making it possible for inducing antigen-specific
immune responses by oral administration of rice-based
mucosal vaccine [34].
To scrutinize whether the blood glucose lowering
effect was solely resulted from the action of the rhIGF-I
in SI rice, total starch contnet of SI and wild type rice
grains was assessed by enzymatic digestion with a-amy-
lase and amyloglucosidase (Megazyme). As depicted in
Supplemental Figure S2, there was no significant differ-
ence in endogenous starch contents between SI and
wild type rice grains. Our results confirmed that the
blood glucose lowering effect was solely due to the
action of rice-derived rhIGF-I.
Recent study demonstrated that rice-codon-modified
rhIGF-1 could also be expressed in transgenic rice
grains. Oral administration of the codon-modified
rhIGF-I could reduce blood glucose in diabetic mice by
enhancing plasma rhIGF-I level. The rhIGF-I produced
by Xie et al. was a fusion protein of 38 kDa, with a C-
terminal ER luminal binding protein, but not native
rhIGF-I [35]. In the present study, native rhIGF-I with
about 7.6 kDa (Figure 2B) could successfully be
expressed and its biological functions were similar to
those of commercial rhIGF-I, as indicated in both in
vitro (Figures 3, 4) and in vivo (Figure 5) analysis.
Hence, our approach might provide an alternative meth-
odology in producing native rhIGF-I. Using a different
approach, rhIGF-I was expressed in rice leaves [36].
Further extraction and purification of the protein from
leaves would be required before the protein could be
utilized. The expression of rhIGF-I in rice grain in the
present study represents a better way of producing func-
tional rhIGF-I that possesses insulin-like biological func-
tions for clinical applications.
T h el i m i t a t i o no ft h i sr e p o r ti st h a ti ti so n l yap r e l i -
minary study to test the feasibility of hIGF-I expression
in transgenic rice. The in vivo s t u d yw ep e r f o r m e dw a s
an acute effect of the rice-derived rhIGF-I on rats.
Long-term study will be carried out to see whether the
rhIGF-I possesses glucose lowering effect and its side
effects in diabetic rats. Besides, the level of IGF-I will be
measured to see whether the glucose lowering effect is
attributed to the rice-derived rhIGF-I. Moreover, as the
rice-derived rhIGF-I was neither isolated nor purified,
attempts will be put on purification of the rice-derived
rhIGF-I for possible clinical uses.
Conclusion
We have successfully expressed native rhIGF-I in rice
grains using transgenic approach. Plant-optimized hIGF-
I cDNA was incorporated in different expression con-
structs and introduced into rice by Agrobacterium-
mediated transformation. One gram of SI rice grain pos-
sessed the maximum activity level equivalent to 3.2 μM
of commercial rhIGF-I. In vitro studies showed that
rice-derived rhIGF-I could induce membrane ruffling
and enhance glucose uptake in L6myc cells. Oral admin-
istration of transgenic rhIGF-I rice confirmed that it
reduced plasma glucose levels in STZ-induced and
Zucker diabetic fatty rats, while it did not have signifi-
cant effect in normal SD rats. Taken together, our find-
ings suggested that biologically active rhIGF-I could be
produced in transgenic rice.
Methods
Chimeric genes construction
The hIGF-I cDNA [37] was first modified to enhance its
expression in plant, with 28.6% change of codons
(Figure 1A) [16]. Three constructs were designed,
namely promoter only construct (I), signal peptide con-
struct (SI) and protein sorting construct (SIK). All of
them were cloned into the twin T-DNA binary vector,
pSB130, for Agrobacterium-mediated transformation in
rice [38]. The binary vector contains two T-DNAs, one
flanking the gene of interest driven by rice glutelin Gt1
promoter while the other flanking the selectable marker,
hygromycin phosphotransferase (HYG) (Figure 1F). It is
believed that the two independent T-DNAs will be inte-
grated into different chromosomes or the same
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regation of the chromosomes, selectable marker-free
transgenic rice with the transgene only can be produced.
For the promoter only construct, the plant codon-opti-
mized hIGF-I cDNA was first amplified to introduce a
5’ BamHI and 3’ KpnI restriction sites by PCR using pri-
mer IBL, 5’ - CGGGATCCATGGGTCCTGAGACCCTC
-3 ’ and IKR, 5’-GGACGGTTCAGGCGAACTC-
CATGGGG - 3’. The PCR product was ligated into the
vector pSB130, resulting in pSB130/Gt1/hIGF-I (I)
(Figure 1C). The signal peptide construct was made
same as the procedure described above except for the
primers used. Primers INL, 5’-CATGCCATGGGTCCT-
GAGACCCTCTGC - 3’ and IKR were used to introduce
NcoI and KpnI sites to the gene fragment. The resulting
construct, pSB130/Gt1/SP/hIGF-I (SI), contained the
modified hIGF-I and glutelin signal peptide (Figure 1D).
For the protein sorting construct, a 5’ NcoI restriction
site and a 3’ KDEL protein sorting sequence were added
to the target gene by using the primers INL and IKKR,
5’ - GAGTTCGGACGGTTCAGGCGATTTCTACTC-
GATACTCCATGGGG - 3’.T h ef i n a lc o n s t r u c tw a s
pSB130/Gt1/SP/hIGF-I/KDEL (SIK) (Figure 1E). To
confirm the sequence fidelity of the chimeric genes,
cycle sequencing was carried out using ABI PRISM
®
dRhodamine Terminator cycle sequencing kit (Applied
Biosystems) and the results were analyzed using ABI
PRISM
® 3100 Genetic Analyzer (Applied Biosystems) as
described in the user manual. The final constructs with
correct sequences were transferred into Agrobacterium
tumefaciens strain EHA105 by heat-shock method [38]
for rice transformation.
Rice transformation and selection
Mature rice seeds of an elite japonica rice variety
Wuyunjing 9 from China were used for Agrobacterium-
mediated transformation previously described [38].
Briefly, mature rice seeds were first sterilized with 50%
Clorox (5.25% sodium hypochlorite) together with 1
drop of Tween 20. Sterilized rice seeds were cultured in
callus induction medium for callus formation. Newly-
formed calli were excised from the endosperm and
immerged in Agrobacterium culture harbouring the
expression constructs. Infected calli were placed in
selection medium to allow resistant calli to form. Resis-
tant calli were removed from the original sample and
cultured in pre-regeneration and regeneration medium
for shoots formation. Roots were allowed to grow in
rooting medium and finally the plantlets were trans-
ferred to soil and grown in greenhouse.
Southern blot analysis
Leaf genomic DNA of T0 transgenic rice plant was iso-
lated by the cetyltrimethylammonium bromide (CTAB)
method as described previously [39]. Fifteen μg of geno-
mic DNA was digested overnight with BamHI, separated
on 0.8% agarose gel and transferred to positively
charged nylon membrane (Roche) using the VacuGen-
eXL Vacuum blotting System (Pharmacia Biotech).
Hybridization and detection were performed in accor-
dance with the method described in the DIG Nucleic
Acid Detection Kit (Roche). Human IGF-I specific
bands were detected by denatured DIG-labeled hIGF-I
probe prepared by PCR using DIG DNA labeling Kit
(Roche).
Western blot analysis
Total seed protein was obtained from grinding mature
T1 transgenic rice seeds (20 mg) into powder and
mixed with 80 μl of Tris extraction buffer (0.125 M
Tris-HCl, 0.1% SDS, pH 6.8). The quantity of seed pro-
tein was determined by the bicinochoninic acid (BCA)
method and bovine serum albumin (BSA) was used as
standard. For Western blot analysis, 150 μg each of total
seed protein extracts were resolved in 10% Tricine SDS-
PAGE and blotted on PVDF membrane (Bio-Rad) using
Towbin buffer (48 mM Tris, 39 mM Glycine and 20%
methanol). The membrane was then incubated in pri-
mary anti-IGF-I (Santa Cruz Biotechnology, Inc) poly-
clonal antibody, followed by AP-conjugated anti-rabbit
immuno-globulin G (Bio-Rad) at a 1:30000 dilution.
Finally the membrane was subjected to non-radioactive
detection with chemiluminescent Starlight™ Substrate
(ICN) as described in the manual of Aurora™ Western
Blot Chemiluminescent Detection System (ICN).
Functional analysis of rice-produced rhIGF-I
A) Membrane ruffling
Rat L6 skeletal muscle cells expressing c-myc epitope-
tagged glucose transporter 4 (GLUT4) (L6myc cells)
[40,41] were maintained in myoblast monolayer culture
in a-minimal essential medium containing 10% (v/v)
fetal bovine serum (FBS) and 1% (v/v) antibiotic-antimy-
cotic solution (100 U/ml penicillin G, 10 mg/ml strepto-
mycin and 25 mg/ml amphotericin B) in an atmosphere
of 5% CO2 at 37°C. Cells were subcultured by trypsini-
zation of subconfluent cultures using 0.25% trypsin.
Myoblasts were plated in medium containing 2% (v/v)
FBS at approximately 4 × 10
4 cells/ml for 5-7 days for
differentiation into myotubes. The differentiated myo-
tubes were deprived of serum for 3 hours and treated
with different concentrations of rhIGF-I extracted from
transgenic rice seeds for 10 minutes at 37°C. After incu-
bation, the myotubes were fixed with 3% (v/v) ice-cold
paraformaldehyde and permeabilized with 0.1% (v/v)
Triton X-100. After blocking in 0.1% BSA, the myotubes
were incubated in Phaloidin and then mounted in Pro-
Long Antifade solution onto glass slides. Samples were
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and a Zeiss LSM 510 META laser scanning confocal
microscope (Carl Zeiss, Jena, Germany). Confocal image
was divided into 900 equal squares for determination of
ruffling intensity. Three images were collected in each
group and the number of squares showing ruffling was
counted, taken average and calculated.
B) 2-Deoxy-[3H]deoxyglucose Uptake
After 24 hours starvation, L6myc myotubes were left
untreated or treated with 100 nmol/l insulin or different
concentrations of transgenic rice seed protein for speci-
fic period at 37°C. Subsequently, cells were washed sev-
eral times with glucose-free HEPES-buffered saline
solution (140 mmol/l NaCl, 20 mmol/l Na-HEPES, pH
7.4, 2.5 mmol/l MgSO4, 5 mmol/l KCl, and 1 mmol/l,
CaCl2). Glucose uptake was measured as described pre-
v i o u s l yb yu s i n g2 - d e o x y - [ 3
H] deoxy-glucose [42] and
each condition was assayed in triplicate.
C) In vivo feeding test
Three different groups of rats were used to study the
oral rice tolerance test (ORTT), including Sprague-Daw-
ley (SD) rats, streptozotocin (STZ)-induced diabetic rats
and Zucker diabetic fatty (ZDF) rats. Male SD and ZDF
rats, aged 5 weeks, were obtained from the Animal Ser-
vices Centre of the Chinese University of Hong Kong
a n da c c l i m a t i z e da t2 3±1 ° Cw i t ha1 2hl i g h t / d a r k
cycle. Food and water intake were given ad libitum.
Male SD rats (350-400 g) were made diabetic by a single
intravenous injection of STZ (Sigma, 50 mg/kg body
weight). The diabetic status of rats was confirmed by
the demonstration of fasting blood glucose level greater
than 16.6 mmol/l after 3 days of STZ injection. For ZDF
rats, they were maintained on a high-fat 5008 Purina
diet (Purina, St Louis, Mo) for 20 weeks. Diabetes was
confirmed by a 2-hour oral glucose tolerance test
(OGTT), in which blood glucose level attained 11.1
mmol/l. For ORTT, normal SD rats, STZ-induced dia-
betic rats and ZDF rats were fasted for 16 hours prior
to feeding with fine rice grains powder of either trans-
genic rhIGF-I rice or wild type rice (4.8 g/kg body
weight) suspended in water by using oral stainless-steel
animal feeding needle. Commercial rhIGF-I was used as
control. The concentrations of blood glucose were col-
lected and measured at 0, 0.5, 1, 2, 2.5 and 3 hours
using blood glucose strips on ONE TOUCH system
(Johnson & Johnson, Milpitas, CA). All procedures were
conducted in accordance with the guidelines set by the
Animal Services Centre of the Chinese University of
Hong Kong.
Determination of starch content of rice
Total starch contents of both transgenic and wild type
rice grains were analyzed according to the manual of
the Total Starch Assay Kit based on the use of
thermostable amyloglucosidase and a-amylase method
(Megazyme). Transgenic rhIGF-I rice and wild type
rice grains were milled to fine powder first, followed
by incubated with a-amylase and amyloglucosidase.
After adding Glucose Determination Reagent to the
treated samples, the absorbance at 510 nm for each
samples were read against the reagent blank, with D-
g l u c o s eb e i n gt h ep o s i t i v ec o n t r o l .
Statistical Analysis
All differences in mean glucose uptake, blood glucose
levels and rice starch content were expressed as mean ±
SD and were estimated by two-tailed Students t-test
analysis. A p value less than 0.05 was considered to be
statistically significant.
Additional material
Additional file 1: Supplemental Figure S1: Southern blot analysis of
genomic DNA from transformants I, SI and SIK. Genomic DNA
extracted from rice leaves of independent transformants was digested
with BamHI, blotted on the positively-charged nylon membrane and
hybridized with DIG-labeled hIGF-I probe. Lane 1: wild type (wt) rice
plant; lanes 2-3: pSB/Gt1/hIGF-I transformants I1 and I2; lanes 4-7: pSB/
Gt1/SP/hIGF-I transformants SI2 to SI5; lanes 8-11: pSB/Gt1/SP/hIGF-I::KDEL
transformants SIK1 to SIK4.
Additional file 2: Supplemental Figure S2: Comparison of the starch
content between the wild type rice (WT) and transgenic IGF-I rice
(SI). The OD reading are 0.590 ± 0.023 and 0.574 ± 0.019, p = 0.119. Data
are shown as means ± SD.
Abbreviations
rhIGF-I: Recombinant human insulin-like growth factor-I; GHIS: growth
hormone insensitivity syndrome; ER: endoplasmic reticulum; KDEL: Lys-Asp-
Glu-Leu; SP: signal peptide; SD: Sprague-Dawley; STZ: streptozotocin; LRP:
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